Compass Pathways Received an $80 Million Boost from Investors to Expand its Exploration of Psilocybin as a Therapy for Treatment-Resistant Depression The Psychedelics Mental Health Company Plans to Run Several... read more →
ATAI Life Sciences Will Use the Proceeds from its $24 Million Convertible Note Financing to Explore the Effects of Psychedelic Medicine on Mental Health A New Group of Renowned Investors... read more →
The Opioid Crisis Has Plagued North America for Decades, and According to the U.S. HHS, it Kills an Estimated 130+ People Per Day in the United States Alone Thanks to... read more →